Objectives: The market entry of effective obesity medications offers promise to patients with obesit...
Read moreTo date, there are two different levers in play under Trump’s “Most Favored Nation”, 1. A drug...
Read moreFor decades, the free market model of the US healthcare system has been very attractive for biotech ...
Read moreAUTHORS: ​Joyce Atim, Rahul Vadehra​ Rare diseases have a significant impact on people worldwide...
Read moreWe examine how real-world evidence strategies help address uncertainties in rare disease treatments ...
Read moreAchieving HTA approval for orphan drugs requires strategic planning, early engagement, strong eviden...
Read moreThe recent appraisal by the National Institute for Health and Care Excellence (NICE) for Iptacopan, ...
Read moreWe're thrilled to announce our participation at World Orphan Drug Congress Europe 2024 in Barcelona ...
Read moreNICE recommends gene therapy for severe beta-thalassaemia, offering hope for improved quality of lif...
Read moreThe World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar...
Read more